Articles

Inhibition of 4EBP phosphorylation mediates the cytotoxic effect of mechanistic target of rapamycin kinase inhibitors in aggressive B-cell lymphomas

Departments of Pathology and Microbiology and Hematology Oncology, University of Nebraska Medical Center, Omaha, NE, USA
Departments of Pathology and Microbiology and Hematology Oncology, University of Nebraska Medical Center, Omaha, NE, USA
Departments of Pathology and Microbiology and Hematology Oncology, University of Nebraska Medical Center, Omaha, NE, USA
Departments of Pathology and Microbiology and Hematology Oncology, University of Nebraska Medical Center, Omaha, NE, USA
Departments of Pathology and Microbiology and Hematology Oncology, University of Nebraska Medical Center, Omaha, NE, USA;The Sino-US Lymphoma Center, Tianjin Medical University Cancer Institute and Hospital, National Cancer Research Center, China
The Sino-US Lymphoma Center, Tianjin Medical University Cancer Institute and Hospital, National Cancer Research Center, China
The Sino-US Lymphoma Center, Tianjin Medical University Cancer Institute and Hospital, National Cancer Research Center, China
The Sino-US Lymphoma Center, Tianjin Medical University Cancer Institute and Hospital, National Cancer Research Center, China
Departments of Pathology and Microbiology and Hematology Oncology, University of Nebraska Medical Center, Omaha, NE, USA
Department of Pathology, City of Hope Medical Center, Duarte, CA, USA
Department of Pathology, City of Hope Medical Center, Duarte, CA, USA
Departments of Pathology and Microbiology and Hematology Oncology, University of Nebraska Medical Center, Omaha, NE, USA;The Sino-US Lymphoma Center, Tianjin Medical University Cancer Institute and Hospital, National Cancer Research Center, China
Vol. 102 No. 4 (2017): April, 2017 https://doi.org/10.3324/haematol.2016.159160